Large Molecular Assembly of Amphotericin B
A R T I C L E S
N-{N-(9-Fluorenylmethoxycarbonyl)-glycyl-3-aminopropyl}-
AmB (8). A solution of 7 (13 mg, 36 µmol) and AmB (50 mg, 54
µmol) in DMF-MeOH (4:3, 7 mL) was stirred for 3 h, and then NaBH3-
CN (14 mg, 216 µmol) was added to the solution. After being stirred
overnight, the solution was poured into diethyl ether (100 mL) to form
a yellow precipitate, which was filtered over Celite and washed with
diethyl ether. The precipitate and the Celite were extracted with CHCl3-
MeOH-H2O 10:6:1 and purified by column chromatography on SiO2
with the same solvent system to afford 8 (19 mg, 43%) as a yellow
solid. Rf 0.63 (CHCl3-MeOH-H2O ) 10:6:1. ESI-MS m/z 1260.4 (M
+ H)+.
Preparation of Derivatives 5 and 5′. To a solution of 8 (19 mg,
15 µmol) in DMF-MeOH (1:1, 4 mL) was added piperidine (500 µL,
5 mmol). After the solution stirred for 30 min, diethyl ether was added
to form a yellow precipitate. The precipitate was filtered over Celite
and washed with diethyl ether. The product was extracted with CHCl3-
MeOH-H2O to give crude 9 (18 mg), which was used for the next
reaction without further purification because of instability. To a solution
of crude 9 (18 mg) in DMF (10 mL) were added diisopropylethylamine
(6 µL, 35 µmol), 1-hydroxybenzotriazole (3.3 mg, 21 µmol), and
PyBOP (8.8 mg, 17 mmol) sequentially. After the mixture stirred for
20 h, it was poured into diethyl ether to form precipitates. The
precipitate was filtered over Celite, washed with diethyl ether, and
extracted with CHCl3-MeOH-H2O. The extract was purified by HPLC
to afford 2 (1.7 mg, 11% for two steps). HPLC conditions: column,
COSMOSIL 5C18-AR-II Φ 4.6 mm × 150 mm; flow rate, 0.5 mL/
min; mobile phase, MeOH-5 mM ammonium acetate (pH 5.3)
changing linearly from 70:30 to 100:0 for 30 min; retention time, 20.0
min. ESI-MS m/z 1020.5 (M + H)+. 1H NMR (500 MHz, DMSO-d6),
see Supporting Information. 5′ was prepared in the same way as 5 by
using [1-13C,15N]glycine as a starting material.
Conclusion
We have designed and prepared a new intramolecular bridged
derivative 5 and showed that 5 excellently retained membrane
permeabilizing activity and selective toxicity characteristic of
AmB. The conformation of 5, restricted with a short-chain
bridge, was similar to that of derivative 3 which has the highest
ergosterol selectivity among homologues with different lengths
of bridges. This indicates that the orientation of aminosugars
in 3 and 5 is critical to the activity of AmB, thus further
confirming the idea that the conformation of the bridged
derivatives reflects the active structure of AmB in the channel
complex.
Isotope-labeled derivative 5′ was then subjected to solid-state
NMR measurements in DMPC membrane preparations, which
demonstrated that 5 forms immobilized aggregates in the
membranes. It was also observed that the aggregate formation
is promoted in the presence of ergosterol, which might be related
to the higher activity of AmB in ergosterol-containing mem-
branes. Because derivative 5 has biological activity and ion-
channel properties similar to those of AmB, it is assumed that
motional properties of 5 somewhat reflect the behaviors of AmB
upon ion-channel formation.
Experimental Section
Materials and Methods. Amphotericin B (AmB), egg phosphati-
dylcholine, amino-alcohols, cholesterol, and ergosterol were from
Nakarai Tesque. 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
was purchased from Avanti Polar Lipid Inc. (Alabaster, AL). [1-13C,15N]-
glycine was from Cambridge Isotope Laboratory (Cambridge, MA).
Deuterated solvents were purchased from Merck. All other chemicals
were obtained from standard venders and used without further purifica-
tion. NMR spectra were recorded on a JEOL GSX-500 spectrometer.
ESI-MS spectra were measured on an LCQ-deca (Thermo Finnigan).
HPLC was performed on a Shimadzu LC-10ADvp with an SPD-
M10Avp photodiode array detector. Thin-layer chromatography (TLC)
was performed on a glass plate precoated with silica gel (E. Merck
Kieselgel 60 F254). Column chromatography was performed with silica
gel 60 (E. Merck, particle size 0.063-0.200 mm, 60-230 mesh).
N-(9-Fluorenylmethoxycarbonyl)-glycyl-3-aminopropanol (6).
Fmoc-glycine was prepared with a standard method. To a stirred
solution of Fmoc-glycine (120 mg, 0.30 mmol) and 3-aminopropanol
(46µL, 40 µmol, 0.60 mmol) in DMF (12 mL) were added diisopro-
pylethylamine (138 µL, 0.80 mmol), 1-hydroxybenzotriazole (74 mg,
0.48 mmol), and PyBOP (208 mg, 0.40 mmol) sequentially. After being
stirred at 23 °C for 16 h, the mixture was diluted with water (100 mL)
and extracted with CHCl3. The organic layer was dried over MgSO4,
concentrated, and purified by column chromatography on SiO2 with
CHCl3-MeOH to give 6 as a white amorphous powder (89 mg, 63%).
Liquid NMR Measurements. The antibiotic solutions were prepared
under dry argon in DMSO-d6 at 5 mM concentration. All liquid NMR
spectra were recorded at 25 °C on a JEOL GSX500 spectrometer (1H
500 MHz). Spectra were processed using Alice2 V.4.1 (JEOL DATUM)
software. Homonuclear two-dimensional spectra COSY, TOCSY (HO-
HAHA), and NOESY were recorded with a 1.5 s recovery delay in the
phase-sensitive mode using the States method as data matrices of 512
(F1) × 1024 (F2) complex data points. Mixing times of 80 ms for
TOCSY and 300 ms for NOESY spectra were used. The spectral width
in both dimensions was 5000 Hz. The data were apodized with shifted
square sine-bell window functions in both F1 and F2 dimensions after
zero-filling in the F2 dimension to obtain a final matrix of 512 (F1) ×
2048 (F2) real data points. Chemical shifts were referenced to the
solvent chemical shift (DMSO-d5(1H), 2.49 ppm.).
Conformation Analysis of 5. All the interproton-distance restraints
between non-J-coupled protons are derived from the two-dimensional
homonuclear NOESY experiments. Interproton restraints were classified
into three categories. Upper bounds were fixed at 2.8, 3.4, and 4.0 Å
for strong, medium, and weak correlations, respectively. A lower bound
was fixed at 1.8 Å, which corresponds to the sum of the hydrogen van
der Waals radii. Pseudo atom corrections of the upper bounds were
applied for distance restraints involving the unresolved methylene and
methyl protons (+1 Å). For stereospecifically assigned diastereotopic
methylene protons, the interproton distances were applied to each proton
according to the NOE peak intensities. When possible, H-C-C-H
dihedral angles were restrained to dihedral domains according to the
1
Rf 0.41 (CHCl3-MeOH ) 5:1). H NMR (500 MHz, CDCl3) δ 7.74
(d, 2H, J ) 7.0 Hz), 7.57 (d, 2H, J ) 7.0 Hz), 7.39 (t, 2H, J ) 7.5
Hz), 7.30 (t, 2H, J ) 7.5 Hz), 6.43 (brs, 1H), 5.38 (brs, 1H), 4.44 (d,
2H, J ) 7.0 Hz), 4.20 (t, 1H, J ) 7.0 Hz), 3.83 (d, 2H), 3.62 (t, 2H),
3.42 (m, 2H), 1.67 (m, 2H).
N-(9-Fluorenylmethoxycarbonyl)-glycyl-3-aminopropanal (7). To
a CH2Cl2 solution (1 mL) of 6 (150 mg, 0.48 mmol) was added Dess-
Martin reagent (220 mg, 0.52 mmol) at 23 °C. After being stirred for
3 h, the solution was quenched with 10 mL of saturated Na2S2O3
solution and extracted with CHCl3. The organic layer was dried over
MgSO4 and concentrated in vacuo, yielding crude 7 as a white
amorphous powder (69 mg, 72%). Rf 0.41 (CHCl3-MeOH ) 5:1). 1H
NMR (500 MHz, CDCl3) δ 9.77 (s, 1H), 7.74 (d, 2H, J ) 7.5 Hz),
7.57 (d, 2H, J ) 7.5 Hz), 7.38 (t, 2H, J ) 7.5 Hz), 7.30 (t, 2H, J ) 7.5
Hz), 6.39 (brs, 1H), 5.38 (brs, 1H), 4.41 (d, 2H, J ) 7.0 Hz), 4.20 (t,
1H, J ) 7.0 Hz), 3.80 (d, 2H), 3.54 (m, 2H), 2.73 (m, 2H).
3
different JHH coupling constants measured using Karplus dihedral
relations with a (30° allowance. Conformation was calculated using
the MacroModel software version 8.529 installed on RedHat Linux 8
OS. Initial atomic coordinates and structure files were generated step-
by-step from the crystal data of N-iodoacetyl AmB.28 The macrolide
ring was treated as a semirigid group, in which a (30° allowance from
the crystal structure28 was given to each C-C single bond upon
calculation. The sampling of the conformational space was performed
9
J. AM. CHEM. SOC. VOL. 128, NO. 36, 2006 11983